Answers are grounded in this paper and cite their sources.
Analyses reveal pegfilgrastim prevents febrile neutropenia in cancer patients, suggesting its efficacy in everyday clinical practice.
Pegfilgrastim (Pelgraz®) treatment appeared to be effective and safe in all-day practice.
No takes yet. Share an insight, caveat, or question.
Steinmetz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: